LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Voyager Therapeutics (NASDAQ: VYGR)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ VYGR Voyager Therapeutics
Ferguson Toby / officer: Chief Medical Officer
04/02/2025
Sell
$3.43
10,086
$35K
157,914
NASDAQ VYGR Voyager Therapeutics
Sandrock Alfred / director, officer: President and CEO
04/02/2025
Sell
$3.43
10,885
$37K
430,931
NASDAQ VYGR Voyager Therapeutics
Carter Todd Alfred / officer: Chief Scientific Officer
02/21/2025
Buy
$4.22
92,000
$388K
92,000
NASDAQ VYGR Voyager Therapeutics
Carter Todd Alfred / officer: Chief Scientific Officer
02/20/2025
Sell
$4.26
3,305
$14K
77,718
NASDAQ VYGR Voyager Therapeutics
Sandrock Alfred / director, officer: President and CEO
02/20/2025
Sell
$4.24
11,702
$50K
296,816
NASDAQ VYGR Voyager Therapeutics
Sandrock Alfred / director, officer: President and CEO
02/21/2025
Buy
$4.22
290,000
$1.224M
290,000
NASDAQ VYGR Voyager Therapeutics
Swartz Robin / officer: COO & CBO
02/21/2025
Buy
$4.22
142,500
$601K
142,500
NASDAQ VYGR Voyager Therapeutics
Swartz Robin / officer: COO & CBO
02/20/2025
Sell
$4.25
3,894
$17K
98,397
NASDAQ VYGR Voyager Therapeutics
Fahey Sandell Jacquelyn / officer: Chief Legal Officer
02/21/2025
Buy
$4.22
83,000
$350K
83,000
NASDAQ VYGR Voyager Therapeutics
Ferguson Toby / officer: Chief Medical Officer
02/21/2025
Buy
$4.22
126,000
$532K
126,000
NASDAQ VYGR Voyager Therapeutics
Jorgensen Nathan D. / officer: Chief Financial Officer
02/21/2025
Buy
$4.22
103,000
$435K
103,000